Sample text that will tell about the scope of bioanalysis offerings provided by Discovery Life Science and how that can impact the research our customers are working on.
Discovery Life Sciences is the premier provider of disease and normal specimens for pharmaceutical, biotechnology, and diagnostic companies worldwide.
We are driven by science. Customers value our consultative, innovative approach that helps them overcome obstacles to reach a faster end result. We engage with our customers to achieve their goals, and that’s why we say we are "Science at your Service”.
Discovery has the largest repository of biosamples and the global logistical systems to acquire,
The Discovery Partners platform is a global, integrated network of more than 165 clinical sources in 25 countries on six continents. We collaborate with these clinical partners to fulfill human biospecimen research needs, and we have a team dedicated to building our growing network.
With a particular emphasis in oncology; cardiology; neurology; and infectious, inflammatory, and autoimmune diseases, Discovery’s catalog includes normal, suspect, and disease-state specimens comprising rare diseases and racially and ethnically diverse exemplars.